S. Riminton

发表

International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors

P. Hawkins, J. Roesler, T. Youngstein, 2017, Rheumatology.

Hospital Supply of Off‐label Immunomodulatory Drugs

R. Burke, S. Riminton, K. O’Connor, 2009 .

A. Gill, M. Barnett, S. Riminton, 2016, Neurology.

Tumefactive demyelination following treatment for relapsing multiple sclerosis with alemtuzumab

A. Coles, M. Barnett, Y. Barnett, 2017, Neurology.

Tuberculosis and treatment with infliximab.

S. Riminton, N. Pearce, Basten Antony, 2002, The New England journal of medicine.

Gastric Cancer Screening in Common Variable Immunodeficiency

G. Ahlenstiel, Ming-Wei Lin, D. van der Poorten, 2018, Journal of Clinical Immunology.

Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting.

R. Ashman, C. Farah, S. Riminton, 2006, Oral microbiology and immunology.

Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by 18F-fluorodeoxyglucose-positron emission tomography: two case reports and a review of the literature

J. Williamson, S. Riminton, S. Limaye, 2017, Journal of Medical Case Reports.

Signaling lymphocytic activation molecule (SLAM)/SLAM-associated protein pathway regulates human B-cell tolerance.

C. Cunningham-Rundles, S. Tangye, J. Church, 2014, The Journal of allergy and clinical immunology.

Signaling Lymphocyte Activated Molecule (SLAM)/SLAM-associated Protein (SAP) Pathway Regulates Human B-cell Tolerance

J. Church, E. Meffre, K. Nichols, 2014 .

Successful implementation of an automated electronic support system for patient safety monitoring: The alemtuzumab in multiple sclerosis safety systems (AMS3) study

M. Barnett, K. Buzzard, S. Riminton, 2018, Multiple sclerosis.

Anti‐cytokine therapies for primary systemic necrotizing vasculitis

R. Buchbinder, L. Barnsley, S. Riminton, 2010 .

Refractory chronic spontaneous urticaria after the use of alemtuzumab in multiple sclerosis

Charles Chan, S. Riminton, Hannah Hu, 2020, Neurology: Neuroimmunology & Neuroinflammation.

Systemic strongyloidiasis complicating HIV: a promising response to ivermectin

S. Riminton, R. Garsia, C. Macleod, 1996, International journal of STD & AIDS.

Are antibody deficiency disorders associated with a narrower range of cancers than other forms of immunodeficiency?

L. Mao, A. Grulich, S. Riminton, 2010, Blood.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype

M. Churchill, D. Cooper, A. Kelleher, 2019, Journal of virus eradication.

Oral amoxicillin-associated anaphylaxis, 1 year after negative penicillin testing and oral amoxicillin challenge.

S. Riminton, S. Limaye, Nicolás Urriola, 2016, The journal of allergy and clinical immunology. In practice.

Primary Immunodeficiency Diseases in Australia and New Zealand

S. Riminton, P. Kirkpatrick, 2007, Journal of Clinical Immunology.

Laryngoceles with airway compromise complicating mucous membrane pemphigoid

D. Novakovic, S. Riminton, L. Morgan, 2018, BMJ Case Reports.

Secreted Lymphotoxin-α Is Essential for the Control of an Intracellular Bacterial Infection

Warwick J. Britton, W. Britton, S. Riminton, 2001, The Journal of experimental medicine.

GENE TARGETING TECHNOLOGY AND ADVANCES IN THE PATHOPHYSIOLOGY OF INFLAMMATION

S. Riminton, 2002, Pathology.

P90: LANADELUMAB EFFICACY AND SAFETY REGARDLESS OF BASELINE ATTACK RATE IN PATIENTS WITH PREVIOUS LONG‐TERM PROPHYLAXIS OF HEREDITARY ANGIOEDEMA: A POST HOC SUBANALYSIS OF HELP OLE

Louise, A. Kelleher, E. Deenick, 2022 .

Myeloperoxidase‐antineutrophil cytoplasmic antibody seroconversion and fulminant vasculitis in Scl‐70‐positive scleroderma

M. Peters, S. Riminton, R. Wyndham, 2007, Internal medicine journal.

Enhanced serum immunoglobulin G clearance in myotonic dystrophy-associated hypogammaglobulinemia: a case series and review of the literature

S. Adelstein, A. McLachlan, S. Riminton, 2019, Journal of Medical Case Reports.

Gastric Cancer Screening in Common Variable Immunodeficiency

G. Ahlenstiel, C. Katelaris, S. Riminton, 2018, Journal of Clinical Immunology.

Monoclonal antibody therapy for non-malignant disease

S. Riminton, S. Swaminathan, 2006 .

Tocilizumab for severe COVID‐19 pneumonia: Case series of 5 Australian patients

C. Farah, S. Riminton, S. Ojaimi, 2020, International journal of rheumatic diseases.

Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure.

C. Mackay, S. Tangye, G. Belz, 2013, Immunity.

Safe and effective use of chromatographically purified intravenous immunoglobulin despite profound anti‐IgA sensitization

S. Riminton, S. Limaye, R. Walls, 2001, Internal medicine journal.

Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure.

C. Mackay, S. Tangye, G. Belz, 2013, Immunity.

Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype

M. Churchill, D. Cooper, A. Kelleher, 2019, Journal of virus eradication.

Re: Atopy and risk of non-Hodgkin lymphoma.

B. Armstrong, A. Hughes, A. Grulich, 2007, Journal of the National Cancer Institute.